Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for...

Area of Science:

• Neuroscience
• Developmental Neurobiology
• Pharmacology

Background:

• Developmental exposure to phencyclidine (PCP), an N-methyl-d-aspartate (NMDA) receptor antagonist, can cause lasting neuronal damage and behavioral deficits.
• Understanding the mechanisms of PCP-induced neurotoxicity is crucial for developing effective interventions and validating animal models.

Purpose of the Study:

• To investigate the neurotoxic effects of developmental PCP exposure in rats.
• To elucidate the underlying molecular mechanisms, including gene expression changes and neuronal cell death.

Main Methods:

• Rats were administered PCP (10mg/kg) on postnatal days 7, 9, and 11.
• Frontal cortex tissues were analyzed using DNA microarray and quantitative RT-PCR.
• Neuronal cell death was assessed using Fluoro-Jade C staining.

Main Results:

• PCP exposure led to up-regulation of N-methyl-d-aspartate (NMDA) receptor 1 (NMDAR1) and pro-apoptotic genes, alongside down-regulation of anti-apoptotic genes.
• Significant alterations were observed in schizophrenia-relevant genes, including Brain-derived neurotrophic factor (Bdnf) and basic helix-loop-helix domain containing, class B, 2 (Bhlhb2).
• Elevated neuronal cell death was confirmed in PCP-treated rats.

Conclusions:

• Developmental PCP exposure induces neurodegeneration, partly via up-regulation of NMDA receptors, increasing vulnerability to glutamate.
• Observed changes in schizophrenia-related genes support the utility of this model for studying the disorder.